由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Missouri版 - zz Illumina Launches TruGenome Undiagnosed Disease Test
相关主题
ILLUMINA这个股票真心不错的, 看数据转载: WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System
Illumina broke 100!忍不住还是要pump ILMN
老盖HiSeq的下一代sequencer出来了
过去一年多用了Mate9和iPhone8+ (转载)请推荐几个生产 Next Generation Sequencing 设备的公司
foundation medicine几个人都很牛逼啊射天狼给评价一下这篇文章?
Re: 什么时机摸大腿比较合适 (转载)纽约时报:华大基因收购“完整基因组”,获华府通过
zz Sequencing IVF Embryos早盘3.23冒险杀入GNOM
zz WashU School of Law launches nation's first online LLM关于genomics/bioinformatics/systems biology再发问
相关话题的讨论汇总
话题: illumina话题: disease话题: genome话题: sequencing
进入Missouri版参与讨论
1 (共1页)
G****a
发帖数: 10208
1
Illumina, Inc. (NASDAQ:ILMN) today announced the launch of its TruGenome
Undiagnosed Disease Test provided by the CLIA-certified, CAP-accredited
Illumina Clinical Services Laboratory (ICSL). This new service uses whole
human genome sequencing to assist physicians in identifying the underlying
genetic cause of a rare or undiagnosed disease. By providing physicians with
more comprehensive information from a single test, the service enables a
broader understanding of the genetic basis for disease.
The ICSL uses proven Illumina next-generation sequencing technology to
provide a complete picture of the genome. Illumina's team of Ph.D.
geneticists and certified medical geneticists with expertise in reviewing
whole-genome data as it pertains to genetic disease performs the analysis
using Illumina's VariantStudio software for rigorous variant classification.
VariantStudio aggregates data from multiple sources into a single database
that is updated as new discoveries are made, ensuring that analysis is based
on current knowledge of clinically relevant gene variants.
"Whole-genome sequencing and interpretation tools have the potential to
benefit the 350 million people worldwide affected by rare diseases, 50
percent of whom are children. By offering the TruGenome Undiagnosed Disease
Test, and partnering with other leading medical institutions that are
beginning to offer whole-genome sequencing tests for the diagnosis of rare
diseases, Illumina intends to demonstrate the clinical utility of whole-
genome sequencing in these cases," said Matt Posard, Senior Vice President
and General Manager of Illumina's Translational and Consumer Genomics
business. "By developing and defining the tools needed to perform whole-
genome sequencing and interpret the results in rare disease cases, we hope
to enable clinical laboratories to offer these services worldwide in the
future. In the end, we all want to see answers for patients and families
facing an undiagnosed disease."
"Whole-genome sequencing is proving to be an invaluable tool in the
identification of rare and undiagnosed disease, and as we learn more about
the human genome and its impact on human health, I expect sequencing to
become a regular component of health care. Medical College of Wisconsin's
partnership with Illumina for clinical testing services has greatly advanced
our capacity in this area," said Howard Jacob, Director of the Human and
Molecular Genetics Center and Warren P. Knowles Chair of Genetics at the
Medical College of Wisconsin.
1 (共1页)
进入Missouri版参与讨论
相关主题
关于genomics/bioinformatics/systems biology再发问foundation medicine几个人都很牛逼啊
[新闻]BGI吃掉Complete Genomics了Re: 什么时机摸大腿比较合适 (转载)
[BSSD] Bioinformatics Postdoc 转行求建议zz Sequencing IVF Embryos
next generation sequencing technology (转载)zz WashU School of Law launches nation's first online LLM
ILLUMINA这个股票真心不错的, 看数据转载: WuXi PharmaTech Purchases an Illumina HiSeq X Ten Sequencing System
Illumina broke 100!忍不住还是要pump ILMN
老盖HiSeq的下一代sequencer出来了
过去一年多用了Mate9和iPhone8+ (转载)请推荐几个生产 Next Generation Sequencing 设备的公司
相关话题的讨论汇总
话题: illumina话题: disease话题: genome话题: sequencing